Rituximab, Combination Chemotherapy, and 90-Yttrium Ibritumomab Tiuxetan for Patients With Stage I or II Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoag Memorial Hospital Presbyterian
SWOG Cancer Research Network
SWOG Cancer Research Network
Fred Hutchinson Cancer Center